Surgically Curable Pulmonary Hypertension: A View From the Experts

Pulmonary Hypertension Registry: a 10-Year Experience

Background: Pulmonary Arterial Hypertension (PAH), a fatal orphan disease, is defined as increased mean Pulmonary Arterial Pressure (mPAP) above 25 mm/Hg, Pulmonary Capillary Wedge Pressure (PCWP) below 15 mm/Hg, and pulmonary vascular Resistance over 3 Wood Unit (WU). Although Pulmonary Hypertension (PH) is a relatively prevalent disease, the idiopathic form (iPAH) is a rare disease with a pre...

The Relationship between Social Entrepreneurship and Sustainable Development from the Social Experts’ Points of View

This research is a survey and exploratory study to present a conceptual model for the sustainable development of Iran based on social entrepreneurship. Its approach for conceptual modeling is based on Path Analysis through Multiple Regression Method. The study has benefited from five questionnaires (four for the Delphi Method’s rounds and another for the conceptual modeling itself). The statist...

Pheochromocytoma: a curable cause of hypertension.

Thalassemia Associated Pulmonary Hypertension

Cardiac disease is the main cause of death in both forms of thalassemia; thalassemia major (TM) and thalassemia intermedia (TI). Pulmonary hypertension (PH) is one of the cardiopulmonary morbidities with high mortality that, if not treated, may trigger right-sided heart failure and premature death. PH is defined as a mean pulmonary artery pressure of ≥25 mmHg at rest or ≥30 mmHg during exercise...

Benefits from the correction of vitamin D deficiency in patients with pulmonary hypertension

Background: Vitamin D (Vit D) is linked to various conditions including musculoskeletal, metabolic and   cardiopulmonary diseases. However, it is not clear whether correction of vit D deficiency exerts any beneficial effect in patients with pulmonary hypertension. Methods: This study was a prospective uncontrolled longitudinal study. Patients with pulmonary hypertension and vit D d...